135 related articles for article (PubMed ID: 19139289)
1. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi.
Xu Y; Pang G; Gao C; Zhao D; Zhou L; Sun S; Wang B
Antimicrob Agents Chemother; 2009 Apr; 53(4):1636-8. PubMed ID: 19139289
[TBL] [Abstract][Full Text] [Related]
2. In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder.
Lalitha P; Vijaykumar R; Prajna NV; Fothergill AW
J Clin Microbiol; 2008 Oct; 46(10):3477-8. PubMed ID: 18701666
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of thimerosal against ocular pathogenic fungi.
Xu Y; Pang G; Zhao D; Gao C; Zhou L; Sun S; Wang B
Antimicrob Agents Chemother; 2010 Jan; 54(1):536-9. PubMed ID: 19841144
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.
Xu Y; Gao C; Li X; He Y; Zhou L; Pang G; Sun S
J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063
[TBL] [Abstract][Full Text] [Related]
5. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Gupta MK; Chandra A; Prakash P; Tilak R
J Mycol Med; 2018 Mar; 28(1):201-205. PubMed ID: 29398639
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.
Lalitha P; Shapiro BL; Loh AR; Fothergill AW; Prajna NV; Srinivasan M; Oldenburg CE; Quigley DA; Chidambaram JD; McLeod SD; Acharya NR; Lietman TM
Br J Ophthalmol; 2011 May; 95(5):744-5. PubMed ID: 21030412
[No Abstract] [Full Text] [Related]
7. In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis.
Betbeze CM; Wu CC; Krohne SG; Stiles J
Am J Vet Res; 2006 Oct; 67(10):1788-93. PubMed ID: 17014335
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of phenylmercuric acetate against ocular pathogenic fungi.
Xu Y; Zhao D; Gao C; Zhou L; Pang G; Sun S
J Antimicrob Chemother; 2012 Aug; 67(8):1941-4. PubMed ID: 22514262
[TBL] [Abstract][Full Text] [Related]
10. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
12. Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against
Rees CA; Bao R; Zegans ME; Cramer RA
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010869
[TBL] [Abstract][Full Text] [Related]
13. Natamycin and Azithromycin Are Synergistic
Guo H; Zhou L; He Y; Gao C; Han L; Xu Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735563
[TBL] [Abstract][Full Text] [Related]
14. Antifungal effect of ophthalmic preservatives phenylmercuric nitrate and benzalkonium chloride on ocular pathogenic filamentous fungi.
Xu Y; He Y; Li X; Gao C; Zhou L; Sun S; Pang G
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):64-7. PubMed ID: 23102555
[TBL] [Abstract][Full Text] [Related]
15. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
Wang L; Wang L; Han L; Yin W
Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Lalitha P; Sun CQ; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Cevallos V; McLeod SD; Acharya NR; Lietman TM;
Am J Ophthalmol; 2014 Feb; 157(2):318-26. PubMed ID: 24439440
[TBL] [Abstract][Full Text] [Related]
18. In vitro synergy of natamycin and voriconazole against clinical isolates of
Sradhanjali S; Yein B; Sharma S; Das S
Br J Ophthalmol; 2018 Jan; 102(1):142-145. PubMed ID: 28982951
[TBL] [Abstract][Full Text] [Related]
19. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
Pearce JW; Giuliano EA; Moore CP
Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
